We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,869

CRS Issues Nanotechnology Policy Primer
  • Shook Hardy & Bacon LLP
  • USA
  • July 8 2016

A new report from the public policy research arm of the U.S. Congress provides an overview of federal research and development (R & D) in


New Meta-Analysis Targets Health Effects of Butter Consumption
  • Shook Hardy & Bacon LLP
  • USA
  • July 8 2016

A meta-analysis examining the effect of dairy fats on health has identified "a small positive association between butter consumption and all-cause


Settlement in Pepsi 4-MEI Suit Preliminarily Approved
  • Shook Hardy & Bacon LLP
  • USA
  • July 8 2016

A California federal court has granted preliminary approval for a settlement agreement in a lawsuit alleging PepsiCo products contain levels of


Diageo to Begin Listing Nutritional Information on Johnnie Walker
  • Shook Hardy & Bacon LLP
  • USA
  • July 8 2016

Diageo will reportedly provide nutritional information on its alcohol product packaging, beginning with Johnnie Walker Red Label. Changes to


Hospital walks back study linking aspartame to leukemia
  • Shook Hardy & Bacon LLP
  • USA
  • October 26 2012

Brigham and Women’s Hospital (BWM) has reportedly walked back a recent study claiming to link aspartame with an increased risk of leukemia, non- Hodgkin’s lymphoma (NHL) and other blood-related cancers


FDA refuses to re-classify tooth-whitening products as drugs
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2014

The U.S. Food and Drug Administration (FDA) has denied a Citizen Petition asking the agency to re-categorize tooth-whitening products as drugs


Decoding patent-eligibility of diagnostic methods
  • Shook Hardy & Bacon LLP
  • USA
  • May 19 2016

Figuring out whether an invention is patent-worthy has become a bit easier, thanks to the Federal Circuit’s clarifications in Genetic Technologies


Florida District Courts Of Appeal Certify Conflict As To Whether Referral Sources Are A Legitimate Business Interest To Support Restrictive Covenants
  • Shook Hardy & Bacon LLP
  • USA
  • January 14 2016

Recently the Fourth and Fifth District Courts of Appeal took conflicting stances as to whether referral sources can be a legitimate business interest


FDA's regulation of trans fats
  • Shook Hardy & Bacon LLP
  • USA
  • January 24 2014

More than 100 years after the advent of artificial trans fats, the U.S. Food and Drug Administration (FDA) has taken the first step toward banning


Claudia Kalb, “Culture of Corpulence,” Newsweek, March 22, 2010
  • Shook Hardy & Bacon LLP
  • USA
  • March 19 2010

This article invokes public-health campaigns of the past, including measures taken to increase seat belt use and stop drunk driving, to call for "big-think solutions" to the nation's obesity problems